Vivani Medical (VANI) announced that the Company will temporarily withdraw the previously announced record date for the planned spin-off of Cortigent, its wholly-owned subsidiary developing brain implant devices with cutting-edge neuromodulation technology, due to delays arising from the current shutdown of the U.S. federal government. Vivani expects to reestablish and announce a new record date as soon as possible.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VANI:
- Vivani Medical’s Strategic Focus and Innovative Product Development Drive Buy Rating
- Vivani Medical Announces Spin-Off of Cortigent
- Vivani Medical announces spin-off of Cortigent subsidiary
- Vivani Medical Shares Insights at Industry Conferences
- Vivani Medical Announces Phase 1 Study for Semaglutide Implant